21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Compositions and methods directed towards sore muscles and joints
#25802Formulation approach to enhance transporter-mediated drug uptake
#25803Solid compositions containing combinations of lactoferrin, colostrum, and citrus pectin
#25804Pharmaceutical formulation for contraception and hormone-replacement therapy
#25805Methods of use of herbal compositions
#25806Salad dressing with weight loss supplement
#25807Cured porous calcium phosphate material and uses thereof
#25808Osmium compounds for reduction of adverse inflammation
#25809Reduction of adverse inflammation
#25810Method of suppressing ongoing acute allograft rejection
#25811Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents
#25812Oxygen carrier system, artificial oxygen carrier, and reducing agent
#25813Chemical combination and method for increasing delivery of Coenzyme Q10
#25814Fixed-dried platelets cross-linked to protein
#25815Combination therapies for multiple sclerosis
#25816Compositions containing melon extracts
#25817Inhibitors of proteasomal activity for stimulating hair growth
#25818Sunburn treatment and sunburn prevention method
#25819Removing dental plaque with krill enzymes
#25820Method and apparatus for oral hygiene products with green tea extract
#25821Medicaments for inhalation comprising an anticholinergic and a betamimetic
#25822Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
#25823Myocardial perfusion imaging methods and compositions
#25824Infiltration of capsaicin into surgical sites and open wounds
#25825Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors
#25826Pharmaceutical formulation
#25827Combination comprising S-[2-([[1-(2-ethylbutyl)cyclohexyl] carbonyl]amino)phenyl] 2-methylpropanethioate and an HMG CoA reductase inhibitor
#25828Cardioprotective agents
#25829Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxygenase-2
#25830Organ fibrosis inhibitor
#25831Compositions comprising epothilones and their use for the treatment of carcinoid syndrome
#25832Therapeutic and diagnostic methods dependent on CYP2A enzymes
#25833Compounds
#25834Drug delivery systems for the prevention and treatment of vascular diseases comprising rapamycin and derivatives thereof
#25835Stable pharmaceutical composition of freeze-dried tetrodotoxin powder
#25836Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes
#25837Statin-MMP inhibitor combinations
#25838Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists
#25839Method of treating lower urinary tract disorders
#25840Heterocyclic compounds as inhibitors of beta-lactamases
#25841Combination of quetiapine and zolmitriptan
#25842Method of treating bacterial infections using gemifloxacin or a salt thereof and a carbapenem antibacterial agent
#25843Method for treating diseases using HSP90-inhibiting agents in combination with platinum coordination complexes
#25844Stability of hormone formulations
#25845Pharmaceutical composition and method for transdermal drug delivery
#25846Enhancement of activity and/or duration of action of selected anti-inflammatory steroids for topical or other local application
#25847Formulation containing anti-inflammatory androstane derivative
#25848Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof
#25849Composition for the prevention and/or treatment of disorders due to abnormal lipid metabolism, comprising propionyl L-carnitine and chitosan
#25850Konjac-mannan and ginseng compositions and methods and uses thereof
#25851Method for treating diseases using HSP90-inhibiting agents in combination with antimetabolites
#25852Chemokines with amino-terminal modifications
#25853Treatment of HIV infection through combined administration of tipranavir and capravirine
#25854Effects of combined administration of farnesyl transferase inhibitors and signal transduction inhibitors
#25855Hepatitis C inhibitor compounds
#25856Apo-2 ligand/trail formulations
#25857Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment
#25858Antiretroviral compositions comprising thymosin alpha peptides and protease inhibitors
#25859Decorin proteoglycan inhibitor of fibrinogen blood clotting
#25860Compositions for improving lipid metabolism
#25861Methods for modulating gap junctions
#25862Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same
#25863Injectable capsaicin
#25864Method of treating non-insulin dependent diabetes mellitus and related complications
#25865Negatively charged polysaccharide derivable from aloe vera
#25866Antimicrobial compositions containing synergistic combinations of quaternary ammonium compounds and essential oils and/or constituents thereof
#25867Non-toxic mucosal disinfectant containing isopropyl alcohol, sesame oil, aloe, and lemon oil
#25868Nutritional composition and method of inhibiting smooth muscle cell contraction thereof
#25869Composition for stimulation of specific metallo-enzymes
#25870Anti-angiogenesis combination therapies comprising pyridazine or pyridine derivatives
#25871Method for treating amyotrophic lateral sclerosis
#25872Method and composition for treating acne
#25873Method of preparing biological materials and preparations produced using same
#25874Liposomal formulation of irinotecan
#25875Orally administered pharmaceutical preparation comprising liposomically encapsulated paclitaxel
#25876Prevention and treatment of amyloidogenic disease
#25877Prevention and treatment of amyloidogenic disease
#25878Prevention and treatment of amyloidogenic disease
#25879Composition for mitigating a pernicious thrombotic event
#25880Composition for human immunostimulation containing Lysozyme and Lactal Bumin
#25881Methods of prevention and treatment of asthma, and allergic conditions
#25882Treatment of respiratory diseases
#25883Mold eradication with Thyme solution and other essential oils
#25884Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
#25885Combination of serotonin reuptake inhibitors and norephinephrine reuptake inhibitors
#25886Ambroxol for the treatment of chronic nociceptive pain
#25887Ambroxol for the treatment of tinnitus
#25888Ambroxol for the treatment of epilepsy
#25889Ambroxol for the treatment of acute pain
#25890Selective anesthetic agents and methods of identifying the same
#25891Compositions containing prodrugs of florfenicol and methods of use
#25892Synergistic medicament containing flavoring agents and having an antagonistic regenerative and/or protagonist decontamination effect
#25893Peroxisome proliferator activated receptor ligand and process for producing the same
#25894Combined agents for treatment of glaucoma
#25895Pyridoxamine for the treatment of diabetic kidney disease
#25896Compositions and methods to treat gastrointestinal disorders
#25897Compositions and methods for treatment of neurological disorders
#25898Use of dipyridamole or mopidamole for treatment and prevention of thromboembolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression of thrombin receptors
#25899Combination of an NMDA receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders
#25900Method for obtaining estrogens from mare's urine
#25901Modulation of interleukin-10 by DHEA
#25902Therapeutic methods for muscular or neuromuscular disorders
#25903Combination of an aldosterone receptor antagonist and an anti-diabetic agent
#25904Anti-fungal formulation of triterpene and essential oil
#25905Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
#25906Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol
#25907Method of treating tuberculosis
#25908Combination product comprising melagatran and dexamethasone
#25909Combinations of enzyme inhibitor-containing preparations and the use thereof
#25910Compositions for improved oxidative status in companion animals
#25911Compositions and methods for modulating S-nitrosoglutathione reductase
#25912Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone
#25913Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
#25914Ophthalmic compositions comprising trefoil factor family peptides
#25915Nucleic acid delivery
#25916Novel multi-component garlic food supplement
#25917Compositions incorporating (-)-hydroxycitric acid, chromium, and gymnemic acid, and related methods for promoting healthy body weight and improving related health factors
#25918Compositions and methods for treating heart disease
#25919Non-toxic disinfectant containing a isopropyl alcohol and sesame oil composition with lemon oil and menthol
#25920Anthocyanin-rich compositions and methods for inhibiting cancer cell growth
#25921Immunopotentiators in thermotherapy for cancer
#25922Suspension or particle-solvent mixture system of zinc-containing calcium phosphate microparticles and therapeutic agent for treating zinc deficiency
#25923Pharmaceutical composition for the treatment of itch
#25924Dual drug dosage forms with improved separation of drugs
#25925Anti-proliferative drugs
#25926Pet food composition for regulating body weight and preventing obesity and related disorders in pets
#25927Prevention and treatment of amyloidogenic disease
#25928Methods of treating liver fibrosis and hepatitis c virus infection
#25929Methods of prevention and treatment of asthama, and allergic conditions
#25930Methods of prevention and treatment of asthma, and allergic conditions
#25931Antimicrobial polymeric biguanide and acidic co-polymer composition and method of use
#25932Method of skin care using lipoic and ascorbic acids
#25933Compositions enriched in phenolic compounds and methods for producing the same
#25934Combination of serotonin reuptake inhibitors and norepinephrine reuptake inhibitors
#25935Use of norepinephrine reuptake inhibitors for the treatment of cognitive failure
#25936Treatment of central neuropathic pain
#25937Composition and method for prevention and treatment of arrhythmias
#25938Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor
#25939Drugs comprising combination of antithrombotic agent with pyrazolone derivative
#25940Combination of SRC Kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases
#25941Synergistic effect of amlodipine and atorvastatin on cholesterol crystal formation inhibition and aortic endothelial cell nitric oxide release
#25942Retinoid receptor pan-antagonists for stimulating chondrogenesis
#25943Combination use of acetylcholinesterase inhibitors and GABAa inverse agonists for the treatment of cognitive disorders
#25944Methods and compositions to enhance the efficacy of phosphodiesterase inhibitors
#25945Pharmaceutical composition containing gabapentin or pregabalin and N-type calcium channel antagonist
#25946Methods for treatment of HIV or malaria using combinations of chloroquine and protease inhibitors
#25947Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists
#25948Mixtures or organic compounds for the treatment of airway diseases
#25949Treatment of liver disease with active vitamin D compounds
#25950Ear and wound treatment
#25951Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
#25952Methods of skin treatment and use of water-soluble β-(1,3) glucans as active agents for producing therapeutic skin treatment agents
#25953Preparation for improving the action of receptors
#25954Synergistic treatment of cancer using immunomers in conjunction with therapeutic agents
#25955Application of water and organic solvent soluble ivermectin for topical and oral use
#25956Use of growth hormone secretagogues for treatment of fibromyalgia
#25957High purity lipopeptides
#25958Treatment of congestive heart failure
#25959Formulation strategies in stabilizing peptides in organic solvents and in dried states
#25960Methods and compositions for optimization of oxygen transport by cell-free systems
#25961Compositions of a cyclooxygenase-2 selective inhibitor and a potassium ion channel modulator for the treatment of central nervous system damage
#25962Humanized antibodies that recognize beta amyloid peptide
#25963Colorant for food and pharmaceuticals
#25964Compositions incorporating (-)-hydroxycitric acid, chromium, and gymnemic acid, and related methods for promoting healthy body weight and improving related health factors
#25965Compositions incorporating (-)-hydroxycitric acid, chromium, and gymnemic acid, and related methods for promoting healthy body weight and improving related health factors
#25966Compositions incorporating (-)-hydroxycitric acid, chromium, and gymnemic acid, and related methods for promoting healthy body weight and improving related health factors
#25967Compositions incorporating (-)-hydroxycitric acid, chromium, and gymnemic acid, and related methods for promoting healthy body weight and improving related health factors
#25968Compositions incorporating(-)-hydroxycitric acid and related methods for promoting fat oxidation
#25969Anti-depression pharmaceutical composition containing extract
#25970Anti-depression pharmaceutical composition containing extract
#25971Anti-depression pharmaceutical composition containing Polygala extract
#25972Anti-neoplastic compositions comprising extracts of black cohosh
#25973Synergistic composition for the treatment of diabetes mellitus
#25974Compositions of plant carbohydrates as dietary supplements
#25975Oral compositions for the treatment of scalp disorders
#25976Nanoparticulate megestrol formulations
#25977Effervescent glucosamine composition
#25978Compositions and methods for delivering a biologically active agent
#25979Nutritional product for enhancing growth and/or strengthening the immune system of equine foals
#25980Food compositions containing creatine
#25981Cosmetic or dermatological active ingredient combination
#25982Compositions and methods for an orally administered inhibitor of biting insects
#25983Composition for neuronal regeneration comprising myelin-specific antibodies and complement proteins
#25984Chemical and physical modulators of bioavailability of inhaled compositions
#25985Carrier with solid fibrinogen and solid thrombin
#25986Effective method for regulating the appearance of skin
#25987Cosmetic and dermatological photoprotective formulations with a content of hydroxybenzophenones, triazine derivatives and/or benzotriazole derivatives
#25988Methods and compositions that enhance bioavailability of coenzyme-Q10
#25989Noble gas-chlorine mixture effective against micro organisms
#25990Heparin barrier coating for controlled drug release
#25991Long-acting drug combinations for the treatment of respiratory complaints
#25992Oxidoreductase inhibitors and methods of screening and using thereof
#25993Treatment of Alzheimer's disease with the R(-) isomer of a 2-arylpropionic acid non-steroidal anti-inflammatory drug alone or in combination with a cyclooxygenase-2 selective inhibitor
#25994Methods for prevention and treatment of gastrointestinal disorders
#25995Treatment of inflammation with a combination of a cyclooxygenase-2 inhibitor and an integrin alpha-v antagonist
#25996Use of organic compounds
#25997Thyroid receptor ligands
#25998Use of anti-emetic for pre and post operative care
#25999Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
#26000Novel substituted benzimidazole dosage forms and method of using same
#26001Use of methylnaltrexone to treat irritable bowel syndrome
#26002Method of improved diuresis in individuals with impaired renal function
#26003Combined use of IMPDH inhibitors with toll-like receptor agonists
#26004THERAPIES RELATING TO COMBINATIONS OF ALDOSE REDUCTASE INHIBITORS AND CYCLOOXYGENASE-2 INHIBITORS
#26005Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration
#26006Telmisartan sodium salt pharmaceutical formulation
#26007Combinations of GABA modulators and anticonvulsants, and atypical antipsychotics
#26008Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as modulators of the estrogen receptors
#26009Hormonal contraceptive product
#26010Aspirin-containing trasdermal pharmaceutical composition for the treatment of calcification
#26011Pharmaceutical combinations for the treatment of cancer
#26012Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof
#26013Increasing electro-gene transfer of nucleic acid molecules into host tissue
#26014Methods for treatment of bacterial infections in impaired renal patients
#26015Dalbavancin compositions for treatment of bacterial infections
#26016Method for increasing cognitive function and neurogenesis
#26017Phage-associated lytic enzymes for treatment of and related conditions
#26018Methods and compositions for treating vascular leak using hepatocyte growth factor
#26019Method of treating corneal transplant rejection
#26020Prevention of hyperinsulinemia in subjects undergoing growth hormone (GH) treatment
#26021Use of antitumoral compound in cancer therapy
#26022Compositions and methods for treating bacterial infections with protein-dalbavancin complexes
#26023Promotion of adoptosis in cancer cells by co-administration of cyclin dependent kinase inhibitiors and cellular differentiation agents
#26024Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
#26025Compositions and methods of delivery of pharmacological agents
#26026Sympathetic nerve-stimulating fragrant compositions
#26027Surface expression of biologically active proteins in bacteria
#26028PSCA: prostate stem cell antigen and uses thereof
#26029Anti-cancer compounds
#26030UTILIZATION OF RUTINS AND AESCINS IN THE TREATMENT OF OCULAR CIRCULATORY DISTURBANCES
#26031Composition for protection and regeneration of structure and function of the liver
#26032Chemical composition and method to bind fat, enhance metabolization, and aid digestion
#26033Regulation of mammalian hair growth
#26034Topical composition for the treatment of psoriasis and related skin disorders
#26035Bowel cleansing agent
#26036Anti-viral compositions and methods of making and using the anti-viral compositions
#26037Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients
#26038Modulation of release from dry powder formulations
#26039Sustained-release, oral pharmaceutical formulations and methods of making and using same
#26040Foods, beverages, condiments, spices and salad dressings with specialized supplements
#26041Nutritional composition for controlling blood sugar level
#26042Drug/drug delivery systems for the prevention and treatment of vascular disease
#26043Method of treating actinic keratosis
#26044Immunostimulatory agents in botanicals
#26045Concentrate comprising green tea, grape skin extract and grape extract, the production thereof and use of the same
#26046Combinations and kits for cancer treatment using selected antibodies to aminophospholipids
#26047Use of B7-H3 as an immunoregulatory agent
#26048Methods for modulating hematopoiesis and vascular growth
#26049Treatment with anti-ErbB2 antibodies
#26050Lactic acid bacteria and its use in direct-fed microbials
#26051Cytokine-expressing cellular vaccine combinations
#26052Uses of vascular endothelial growth factor and type I collagen inducible protein (VCIP)
#26053Compositions and methods for treating coronavirus infection and SARS
#26054Method of treating estrogen responsive breast cancer
#26055Method of pre-sensitizing cancer prior to treament with radiation and/or chemotherapy and a novel cytokine mixture
#26056Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture
#26057External skin compositions
#26058One and only toe nail/finger nail fungus killer
#26059Method for treating cannabis induced anxiety
#26060Micro-RNA profiling, compositions, and methods of treating diseases
#26061Salts of cycloserine compounds and applications thereof
#26062Methods for treating pain associated with sickle cell disease
#26063Therapy and prevention of prion protein complex infections
#26064Antibiotic solution and method of injection to prevent ophthalmic infections
#26065Device for titrating basal insulin
#26066Methods and compositions for treating cancer
#26067Method for treating cannabis induced anxiety
#260685-substituted 2,4-thiazolidinediones (thiohydantoins), pseudothiohydantoins, and propseudothiohydantoins for use as antiviral agents
#26069Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues
#26070Post-transplantation prophylaxis and treatments for antibody-mediated rejection of solid organ transplant
#26071Topical skin health improvement compositions and administrations thereof
#26072Vaporizable cannabinoid compositions
#26073Macrocyclic compound and uses thereof
#26074Homeopathic formulations
#26075Process for synthesis of Eliglustat and intermediate compounds thereof
#26076Biocompatible dental putty formulations for controlled release of bupivacaine
#26077Extended release methazolamide formulation
#26078Solid dispersion formulation
#26079Modulation of T cell signaling via slat association with IP3R1
#26080Deodorizing and skin cleaning
#26081System to verify identity of patient receiving medication and monitoring the dispensing of medication to the patient including monitoring the development of the medication form where the seeds are obtained, how the plant was cultivated, where the medical portion of the plant was harvested and converted into the medication to be dispensed to a patient
#26082Methods of administering anti-TNFα antibodies